COVID-19 Impact on Primary Care POC Diagnostics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Primary Care POC Diagnostics, including the following market information:
Major competitors identified in this market include Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere, etc.
Based on the Region:
- Global Primary Care POC Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Primary Care POC Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Primary Care POC Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Primary Care POC Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Glucose Testing
- Hb1Ac
- Coagulation
- Fertility
- Pharmacy & Retail Clinics
- Physician Office
- Urgent Care Clinics
- Non-practice Clinics
- Cardiac Markers
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Primary Care POC Diagnostics Industry
1.7 COVID-19 Impact: Primary Care POC Diagnostics Market Trends
2 GLOBAL PRIMARY CARE POC DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Primary Care POC Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Primary Care POC Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Primary Care POC Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Primary Care POC Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Primary Care POC Diagnostics Market
3.4 Key Players Primary Care POC Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON PRIMARY CARE POC DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Glucose Testing
1.4.2 Hb1Ac
1.4.3 Coagulation
1.4.4 Fertility
4.2 By Type, Global Primary Care POC Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON PRIMARY CARE POC DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Pharmacy & Retail Clinics
5.5.2 Physician Office
5.5.3 Urgent Care Clinics
5.5.4 Non-practice Clinics
5.5.5 Cardiac Markers
5.2 By Application, Global Primary Care POC Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Primary Care POC Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Primary Care POC Diagnostics Quarterly Revenue, 2020
7.1.3 Abbott Primary Care POC Diagnostics Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Business Overview
7.2.2 ADI/American Diagnostica Primary Care POC Diagnostics Quarterly Revenue, 2020
7.2.3 ADI/American Diagnostica Primary Care POC Diagnostics Product Introduction
7.2.4 ADI/American Diagnostica Response to COVID-19 and Related Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Business Overview
7.3.2 Agilent Technologies Primary Care POC Diagnostics Quarterly Revenue, 2020
7.3.3 Agilent Technologies Primary Care POC Diagnostics Product Introduction
7.3.4 Agilent Technologies Response to COVID-19 and Related Developments
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Business Overview
7.4.2 Alere/Biosite/Inverness Primary Care POC Diagnostics Quarterly Revenue, 2020
7.4.3 Alere/Biosite/Inverness Primary Care POC Diagnostics Product Introduction
7.4.4 Alere/Biosite/Inverness Response to COVID-19 and Related Developments
7.5 Axis-Shield
7.5.1 Axis-Shield Business Overview
7.5.2 Axis-Shield Primary Care POC Diagnostics Quarterly Revenue, 2020
7.5.3 Axis-Shield Primary Care POC Diagnostics Product Introduction
7.5.4 Axis-Shield Response to COVID-19 and Related Developments
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Business Overview
7.6.2 Beckman Coulter/Danaher Primary Care POC Diagnostics Quarterly Revenue, 2020
7.6.3 Beckman Coulter/Danaher Primary Care POC Diagnostics Product Introduction
7.6.4 Beckman Coulter/Danaher Response to COVID-19 and Related Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Business Overview
7.7.2 Becton Dickinson Primary Care POC Diagnostics Quarterly Revenue, 2020
7.7.3 Becton Dickinson Primary Care POC Diagnostics Product Introduction
7.7.4 Becton Dickinson Response to COVID-19 and Related Developments
7.8 Bio/Data
7.8.1 Bio/Data Business Overview
7.8.2 Bio/Data Primary Care POC Diagnostics Quarterly Revenue, 2020
7.8.3 Bio/Data Primary Care POC Diagnostics Product Introduction
7.8.4 Bio/Data Response to COVID-19 and Related Developments
7.9 Decode Genetics
7.9.1 Decode Genetics Business Overview
7.9.2 Decode Genetics Primary Care POC Diagnostics Quarterly Revenue, 2020
7.9.3 Decode Genetics Primary Care POC Diagnostics Product Introduction
7.9.4 Decode Genetics Response to COVID-19 and Related Developments
7.10 Diadexus
7.10.1 Diadexus Business Overview
7.10.2 Diadexus Primary Care POC Diagnostics Quarterly Revenue, 2020
7.10.3 Diadexus Primary Care POC Diagnostics Product Introduction
7.10.4 Diadexus Response to COVID-19 and Related Developments
7.11 Diagnocure
7.11.1 Diagnocure Business Overview
7.11.2 Diagnocure Primary Care POC Diagnostics Quarterly Revenue, 2020
7.11.3 Diagnocure Primary Care POC Diagnostics Product Introduction
7.11.4 Diagnocure Response to COVID-19 and Related Developments
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Business Overview
7.12.2 Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Quarterly Revenue, 2020
7.12.3 Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Product Introduction
7.12.4 Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
7.13 Diamedix
7.13.1 Diamedix Business Overview
7.13.2 Diamedix Primary Care POC Diagnostics Quarterly Revenue, 2020
7.13.3 Diamedix Primary Care POC Diagnostics Product Introduction
7.13.4 Diamedix Response to COVID-19 and Related Developments
7.14 Polymedco
7.14.1 Polymedco Business Overview
7.14.2 Polymedco Primary Care POC Diagnostics Quarterly Revenue, 2020
7.14.3 Polymedco Primary Care POC Diagnostics Product Introduction
7.14.4 Polymedco Response to COVID-19 and Related Developments
7.15 Qiagen
7.15.1 Qiagen Business Overview
7.15.2 Qiagen Primary Care POC Diagnostics Quarterly Revenue, 2020
7.15.3 Qiagen Primary Care POC Diagnostics Product Introduction
7.15.4 Qiagen Response to COVID-19 and Related Developments
7.16 Roche
7.16.1 Roche Business Overview
7.16.2 Roche Primary Care POC Diagnostics Quarterly Revenue, 2020
7.16.3 Roche Primary Care POC Diagnostics Product Introduction
7.16.4 Roche Response to COVID-19 and Related Developments
7.17 SDIX
7.17.1 SDIX Business Overview
7.17.2 SDIX Primary Care POC Diagnostics Quarterly Revenue, 2020
7.17.3 SDIX Primary Care POC Diagnostics Product Introduction
7.17.4 SDIX Response to COVID-19 and Related Developments
7.18 Sequenom
7.18.1 Sequenom Business Overview
7.18.2 Sequenom Primary Care POC Diagnostics Quarterly Revenue, 2020
7.18.3 Sequenom Primary Care POC Diagnostics Product Introduction
7.18.4 Sequenom Response to COVID-19 and Related Developments
7.19 Siemens
7.19.1 Siemens Business Overview
7.19.2 Siemens Primary Care POC Diagnostics Quarterly Revenue, 2020
7.19.3 Siemens Primary Care POC Diagnostics Product Introduction
7.19.4 Siemens Response to COVID-19 and Related Developments
7.20 Sienco
7.20.1 Sienco Business Overview
7.20.2 Sienco Primary Care POC Diagnostics Quarterly Revenue, 2020
7.20.3 Sienco Primary Care POC Diagnostics Product Introduction
7.20.4 Sienco Response to COVID-19 and Related Developments
7.21 Sysmex
7.21.1 Sysmex Business Overview
7.21.2 Sysmex Primary Care POC Diagnostics Quarterly Revenue, 2020
7.21.3 Sysmex Primary Care POC Diagnostics Product Introduction
7.21.4 Sysmex Response to COVID-19 and Related Developments
7.22 Takara Bio
7.22.1 Takara Bio Business Overview
7.22.2 Takara Bio Primary Care POC Diagnostics Quarterly Revenue, 2020
7.22.3 Takara Bio Primary Care POC Diagnostics Product Introduction
7.22.4 Takara Bio Response to COVID-19 and Related Developments
7.23 ThermoFisher
7.23.1 ThermoFisher Business Overview
7.23.2 ThermoFisher Primary Care POC Diagnostics Quarterly Revenue, 2020
7.23.3 ThermoFisher Primary Care POC Diagnostics Product Introduction
7.23.4 ThermoFisher Response to COVID-19 and Related Developments
7.24 Tosoh
7.24.1 Tosoh Business Overview
7.24.2 Tosoh Primary Care POC Diagnostics Quarterly Revenue, 2020
7.24.3 Tosoh Primary Care POC Diagnostics Product Introduction
7.24.4 Tosoh Response to COVID-19 and Related Developments
7.25 Wako
7.25.1 Wako Business Overview
7.25.2 Wako Primary Care POC Diagnostics Quarterly Revenue, 2020
7.25.3 Wako Primary Care POC Diagnostics Product Introduction
7.25.4 Wako Response to COVID-19 and Related Developments
7.26 Zycare/Alere
7.26.1 Zycare/Alere Business Overview
7.26.2 Zycare/Alere Primary Care POC Diagnostics Quarterly Revenue, 2020
7.26.3 Zycare/Alere Primary Care POC Diagnostics Product Introduction
7.26.4 Zycare/Alere Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Primary Care POC Diagnostics Industry
1.7 COVID-19 Impact: Primary Care POC Diagnostics Market Trends
2 GLOBAL PRIMARY CARE POC DIAGNOSTICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Primary Care POC Diagnostics Business Impact Assessment - COVID-19
2.1.1 Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Primary Care POC Diagnostics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Primary Care POC Diagnostics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Primary Care POC Diagnostics Headquarters and Area Served
3.3 Date of Key Players Enter into Primary Care POC Diagnostics Market
3.4 Key Players Primary Care POC Diagnostics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON PRIMARY CARE POC DIAGNOSTICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Glucose Testing
1.4.2 Hb1Ac
1.4.3 Coagulation
1.4.4 Fertility
4.2 By Type, Global Primary Care POC Diagnostics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON PRIMARY CARE POC DIAGNOSTICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Pharmacy & Retail Clinics
5.5.2 Physician Office
5.5.3 Urgent Care Clinics
5.5.4 Non-practice Clinics
5.5.5 Cardiac Markers
5.2 By Application, Global Primary Care POC Diagnostics Market Size, 2019-2021
5.2.1 By Application, Global Primary Care POC Diagnostics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Primary Care POC Diagnostics Quarterly Revenue, 2020
7.1.3 Abbott Primary Care POC Diagnostics Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 ADI/American Diagnostica
7.2.1 ADI/American Diagnostica Business Overview
7.2.2 ADI/American Diagnostica Primary Care POC Diagnostics Quarterly Revenue, 2020
7.2.3 ADI/American Diagnostica Primary Care POC Diagnostics Product Introduction
7.2.4 ADI/American Diagnostica Response to COVID-19 and Related Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Business Overview
7.3.2 Agilent Technologies Primary Care POC Diagnostics Quarterly Revenue, 2020
7.3.3 Agilent Technologies Primary Care POC Diagnostics Product Introduction
7.3.4 Agilent Technologies Response to COVID-19 and Related Developments
7.4 Alere/Biosite/Inverness
7.4.1 Alere/Biosite/Inverness Business Overview
7.4.2 Alere/Biosite/Inverness Primary Care POC Diagnostics Quarterly Revenue, 2020
7.4.3 Alere/Biosite/Inverness Primary Care POC Diagnostics Product Introduction
7.4.4 Alere/Biosite/Inverness Response to COVID-19 and Related Developments
7.5 Axis-Shield
7.5.1 Axis-Shield Business Overview
7.5.2 Axis-Shield Primary Care POC Diagnostics Quarterly Revenue, 2020
7.5.3 Axis-Shield Primary Care POC Diagnostics Product Introduction
7.5.4 Axis-Shield Response to COVID-19 and Related Developments
7.6 Beckman Coulter/Danaher
7.6.1 Beckman Coulter/Danaher Business Overview
7.6.2 Beckman Coulter/Danaher Primary Care POC Diagnostics Quarterly Revenue, 2020
7.6.3 Beckman Coulter/Danaher Primary Care POC Diagnostics Product Introduction
7.6.4 Beckman Coulter/Danaher Response to COVID-19 and Related Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Business Overview
7.7.2 Becton Dickinson Primary Care POC Diagnostics Quarterly Revenue, 2020
7.7.3 Becton Dickinson Primary Care POC Diagnostics Product Introduction
7.7.4 Becton Dickinson Response to COVID-19 and Related Developments
7.8 Bio/Data
7.8.1 Bio/Data Business Overview
7.8.2 Bio/Data Primary Care POC Diagnostics Quarterly Revenue, 2020
7.8.3 Bio/Data Primary Care POC Diagnostics Product Introduction
7.8.4 Bio/Data Response to COVID-19 and Related Developments
7.9 Decode Genetics
7.9.1 Decode Genetics Business Overview
7.9.2 Decode Genetics Primary Care POC Diagnostics Quarterly Revenue, 2020
7.9.3 Decode Genetics Primary Care POC Diagnostics Product Introduction
7.9.4 Decode Genetics Response to COVID-19 and Related Developments
7.10 Diadexus
7.10.1 Diadexus Business Overview
7.10.2 Diadexus Primary Care POC Diagnostics Quarterly Revenue, 2020
7.10.3 Diadexus Primary Care POC Diagnostics Product Introduction
7.10.4 Diadexus Response to COVID-19 and Related Developments
7.11 Diagnocure
7.11.1 Diagnocure Business Overview
7.11.2 Diagnocure Primary Care POC Diagnostics Quarterly Revenue, 2020
7.11.3 Diagnocure Primary Care POC Diagnostics Product Introduction
7.11.4 Diagnocure Response to COVID-19 and Related Developments
7.12 Diagnostica Stago/Trinity Biotech
7.12.1 Diagnostica Stago/Trinity Biotech Business Overview
7.12.2 Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Quarterly Revenue, 2020
7.12.3 Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Product Introduction
7.12.4 Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
7.13 Diamedix
7.13.1 Diamedix Business Overview
7.13.2 Diamedix Primary Care POC Diagnostics Quarterly Revenue, 2020
7.13.3 Diamedix Primary Care POC Diagnostics Product Introduction
7.13.4 Diamedix Response to COVID-19 and Related Developments
7.14 Polymedco
7.14.1 Polymedco Business Overview
7.14.2 Polymedco Primary Care POC Diagnostics Quarterly Revenue, 2020
7.14.3 Polymedco Primary Care POC Diagnostics Product Introduction
7.14.4 Polymedco Response to COVID-19 and Related Developments
7.15 Qiagen
7.15.1 Qiagen Business Overview
7.15.2 Qiagen Primary Care POC Diagnostics Quarterly Revenue, 2020
7.15.3 Qiagen Primary Care POC Diagnostics Product Introduction
7.15.4 Qiagen Response to COVID-19 and Related Developments
7.16 Roche
7.16.1 Roche Business Overview
7.16.2 Roche Primary Care POC Diagnostics Quarterly Revenue, 2020
7.16.3 Roche Primary Care POC Diagnostics Product Introduction
7.16.4 Roche Response to COVID-19 and Related Developments
7.17 SDIX
7.17.1 SDIX Business Overview
7.17.2 SDIX Primary Care POC Diagnostics Quarterly Revenue, 2020
7.17.3 SDIX Primary Care POC Diagnostics Product Introduction
7.17.4 SDIX Response to COVID-19 and Related Developments
7.18 Sequenom
7.18.1 Sequenom Business Overview
7.18.2 Sequenom Primary Care POC Diagnostics Quarterly Revenue, 2020
7.18.3 Sequenom Primary Care POC Diagnostics Product Introduction
7.18.4 Sequenom Response to COVID-19 and Related Developments
7.19 Siemens
7.19.1 Siemens Business Overview
7.19.2 Siemens Primary Care POC Diagnostics Quarterly Revenue, 2020
7.19.3 Siemens Primary Care POC Diagnostics Product Introduction
7.19.4 Siemens Response to COVID-19 and Related Developments
7.20 Sienco
7.20.1 Sienco Business Overview
7.20.2 Sienco Primary Care POC Diagnostics Quarterly Revenue, 2020
7.20.3 Sienco Primary Care POC Diagnostics Product Introduction
7.20.4 Sienco Response to COVID-19 and Related Developments
7.21 Sysmex
7.21.1 Sysmex Business Overview
7.21.2 Sysmex Primary Care POC Diagnostics Quarterly Revenue, 2020
7.21.3 Sysmex Primary Care POC Diagnostics Product Introduction
7.21.4 Sysmex Response to COVID-19 and Related Developments
7.22 Takara Bio
7.22.1 Takara Bio Business Overview
7.22.2 Takara Bio Primary Care POC Diagnostics Quarterly Revenue, 2020
7.22.3 Takara Bio Primary Care POC Diagnostics Product Introduction
7.22.4 Takara Bio Response to COVID-19 and Related Developments
7.23 ThermoFisher
7.23.1 ThermoFisher Business Overview
7.23.2 ThermoFisher Primary Care POC Diagnostics Quarterly Revenue, 2020
7.23.3 ThermoFisher Primary Care POC Diagnostics Product Introduction
7.23.4 ThermoFisher Response to COVID-19 and Related Developments
7.24 Tosoh
7.24.1 Tosoh Business Overview
7.24.2 Tosoh Primary Care POC Diagnostics Quarterly Revenue, 2020
7.24.3 Tosoh Primary Care POC Diagnostics Product Introduction
7.24.4 Tosoh Response to COVID-19 and Related Developments
7.25 Wako
7.25.1 Wako Business Overview
7.25.2 Wako Primary Care POC Diagnostics Quarterly Revenue, 2020
7.25.3 Wako Primary Care POC Diagnostics Product Introduction
7.25.4 Wako Response to COVID-19 and Related Developments
7.26 Zycare/Alere
7.26.1 Zycare/Alere Business Overview
7.26.2 Zycare/Alere Primary Care POC Diagnostics Quarterly Revenue, 2020
7.26.3 Zycare/Alere Primary Care POC Diagnostics Product Introduction
7.26.4 Zycare/Alere Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Primary Care POC Diagnostics Assessment
Table 9. COVID-19 Impact: Primary Care POC Diagnostics Market Trends
Table 10. COVID-19 Impact Global Primary Care POC Diagnostics Market Size
Table 11. Global Primary Care POC Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Primary Care POC Diagnostics Market Growth Drivers
Table 14. Global Primary Care POC Diagnostics Market Restraints
Table 15. Global Primary Care POC Diagnostics Market Opportunities
Table 16. Global Primary Care POC Diagnostics Market Challenges
Table 17. By Players, Primary Care POC Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Primary Care POC Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Primary Care POC Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Primary Care POC Diagnostics Market
Table 21. Key Players Primary Care POC Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Primary Care POC Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Primary Care POC Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Primary Care POC Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Business Overview
Table 58. Abbott Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Primary Care POC Diagnostics Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. ADI/American Diagnostica Business Overview
Table 62. ADI/American Diagnostica Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. ADI/American Diagnostica Primary Care POC Diagnostics Product
Table 64. ADI/American Diagnostica Response to COVID-19 and Related Developments
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Agilent Technologies Primary Care POC Diagnostics Product
Table 68. Agilent Technologies Response to COVID-19 and Related Developments
Table 69. Alere/Biosite/Inverness Business Overview
Table 70. Alere/Biosite/Inverness Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Alere/Biosite/Inverness Primary Care POC Diagnostics Product
Table 72. Alere/Biosite/Inverness Response to COVID-19 and Related Developments
Table 73. Axis-Shield Business Overview
Table 74. Axis-Shield Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Axis-Shield Primary Care POC Diagnostics Product
Table 76. Axis-Shield Response to COVID-19 and Related Developments
Table 77. Beckman Coulter/Danaher Business Overview
Table 78. Beckman Coulter/Danaher Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Beckman Coulter/Danaher Primary Care POC Diagnostics Product
Table 80. Beckman Coulter/Danaher Response to COVID-19 and Related Developments
Table 81. Becton Dickinson Business Overview
Table 82. Becton Dickinson Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Becton Dickinson Primary Care POC Diagnostics Product
Table 84. Becton Dickinson Response to COVID-19 and Related Developments
Table 85. Bio/Data Business Overview
Table 86. Bio/Data Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bio/Data Primary Care POC Diagnostics Product
Table 88. Bio/Data Response to COVID-19 and Related Developments
Table 89. Decode Genetics Business Overview
Table 90. Decode Genetics Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Decode Genetics Primary Care POC Diagnostics Product
Table 92. Decode Genetics Response to COVID-19 and Related Developments
Table 93. Diadexus Business Overview
Table 94. Diadexus Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Diadexus Primary Care POC Diagnostics Product
Table 96. Diadexus Response to COVID-19 and Related Developments
Table 97. Diagnocure Business Overview
Table 98. Diagnocure Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Diagnocure Primary Care POC Diagnostics Product
Table 100. Diagnocure Response to COVID-19 and Related Developments
Table 101. Diagnostica Stago/Trinity Biotech Business Overview
Table 102. Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Product
Table 104. Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
Table 105. Diamedix Business Overview
Table 106. Diamedix Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Diamedix Primary Care POC Diagnostics Product
Table 108. Diamedix Response to COVID-19 and Related Developments
Table 109. Polymedco Business Overview
Table 110. Polymedco Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Polymedco Primary Care POC Diagnostics Product
Table 112. Polymedco Response to COVID-19 and Related Developments
Table 113. Qiagen Business Overview
Table 114. Qiagen Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Qiagen Primary Care POC Diagnostics Product
Table 116. Qiagen Response to COVID-19 and Related Developments
Table 117. Roche Business Overview
Table 118. Roche Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Roche Primary Care POC Diagnostics Product
Table 120. Roche Response to COVID-19 and Related Developments
Table 121. SDIX Business Overview
Table 122. SDIX Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. SDIX Primary Care POC Diagnostics Product
Table 124. SDIX Response to COVID-19 and Related Developments
Table 125. Sequenom Business Overview
Table 126. Sequenom Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Sequenom Primary Care POC Diagnostics Product
Table 128. Sequenom Response to COVID-19 and Related Developments
Table 129. Siemens Business Overview
Table 130. Siemens Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Siemens Primary Care POC Diagnostics Product
Table 132. Siemens Response to COVID-19 and Related Developments
Table 133. Sienco Business Overview
Table 134. Sienco Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Sienco Primary Care POC Diagnostics Product
Table 136. Sienco Response to COVID-19 and Related Developments
Table 137. Sysmex Business Overview
Table 138. Sysmex Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Sysmex Primary Care POC Diagnostics Product
Table 140. Sysmex Response to COVID-19 and Related Developments
Table 141. Takara Bio Business Overview
Table 142. Takara Bio Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Takara Bio Primary Care POC Diagnostics Product
Table 144. Takara Bio Response to COVID-19 and Related Developments
Table 145. ThermoFisher Business Overview
Table 146. ThermoFisher Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. ThermoFisher Primary Care POC Diagnostics Product
Table 148. ThermoFisher Response to COVID-19 and Related Developments
Table 149. Tosoh Business Overview
Table 150. Tosoh Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 151. Tosoh Primary Care POC Diagnostics Product
Table 152. Tosoh Response to COVID-19 and Related Developments
Table 153. Wako Business Overview
Table 154. Wako Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 155. Wako Primary Care POC Diagnostics Product
Table 156. Wako Response to COVID-19 and Related Developments
Table 157. Zycare/Alere Business Overview
Table 158. Zycare/Alere Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 159. Zycare/Alere Primary Care POC Diagnostics Product
Table 160. Zycare/Alere Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Primary Care POC Diagnostics Assessment
Table 9. COVID-19 Impact: Primary Care POC Diagnostics Market Trends
Table 10. COVID-19 Impact Global Primary Care POC Diagnostics Market Size
Table 11. Global Primary Care POC Diagnostics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Primary Care POC Diagnostics Market Growth Drivers
Table 14. Global Primary Care POC Diagnostics Market Restraints
Table 15. Global Primary Care POC Diagnostics Market Opportunities
Table 16. Global Primary Care POC Diagnostics Market Challenges
Table 17. By Players, Primary Care POC Diagnostics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Primary Care POC Diagnostics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Primary Care POC Diagnostics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Primary Care POC Diagnostics Market
Table 21. Key Players Primary Care POC Diagnostics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Primary Care POC Diagnostics Market Size 2019-2021, (US$ Million)
Table 24. Global Primary Care POC Diagnostics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Primary Care POC Diagnostics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Primary Care POC Diagnostics Market Size, 2019-2021 (US$ Million)
Table 57. Abbott Business Overview
Table 58. Abbott Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Primary Care POC Diagnostics Product
Table 60. Abbott Response to COVID-19 and Related Developments
Table 61. ADI/American Diagnostica Business Overview
Table 62. ADI/American Diagnostica Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. ADI/American Diagnostica Primary Care POC Diagnostics Product
Table 64. ADI/American Diagnostica Response to COVID-19 and Related Developments
Table 65. Agilent Technologies Business Overview
Table 66. Agilent Technologies Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Agilent Technologies Primary Care POC Diagnostics Product
Table 68. Agilent Technologies Response to COVID-19 and Related Developments
Table 69. Alere/Biosite/Inverness Business Overview
Table 70. Alere/Biosite/Inverness Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Alere/Biosite/Inverness Primary Care POC Diagnostics Product
Table 72. Alere/Biosite/Inverness Response to COVID-19 and Related Developments
Table 73. Axis-Shield Business Overview
Table 74. Axis-Shield Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Axis-Shield Primary Care POC Diagnostics Product
Table 76. Axis-Shield Response to COVID-19 and Related Developments
Table 77. Beckman Coulter/Danaher Business Overview
Table 78. Beckman Coulter/Danaher Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Beckman Coulter/Danaher Primary Care POC Diagnostics Product
Table 80. Beckman Coulter/Danaher Response to COVID-19 and Related Developments
Table 81. Becton Dickinson Business Overview
Table 82. Becton Dickinson Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Becton Dickinson Primary Care POC Diagnostics Product
Table 84. Becton Dickinson Response to COVID-19 and Related Developments
Table 85. Bio/Data Business Overview
Table 86. Bio/Data Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bio/Data Primary Care POC Diagnostics Product
Table 88. Bio/Data Response to COVID-19 and Related Developments
Table 89. Decode Genetics Business Overview
Table 90. Decode Genetics Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Decode Genetics Primary Care POC Diagnostics Product
Table 92. Decode Genetics Response to COVID-19 and Related Developments
Table 93. Diadexus Business Overview
Table 94. Diadexus Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Diadexus Primary Care POC Diagnostics Product
Table 96. Diadexus Response to COVID-19 and Related Developments
Table 97. Diagnocure Business Overview
Table 98. Diagnocure Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Diagnocure Primary Care POC Diagnostics Product
Table 100. Diagnocure Response to COVID-19 and Related Developments
Table 101. Diagnostica Stago/Trinity Biotech Business Overview
Table 102. Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Diagnostica Stago/Trinity Biotech Primary Care POC Diagnostics Product
Table 104. Diagnostica Stago/Trinity Biotech Response to COVID-19 and Related Developments
Table 105. Diamedix Business Overview
Table 106. Diamedix Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Diamedix Primary Care POC Diagnostics Product
Table 108. Diamedix Response to COVID-19 and Related Developments
Table 109. Polymedco Business Overview
Table 110. Polymedco Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Polymedco Primary Care POC Diagnostics Product
Table 112. Polymedco Response to COVID-19 and Related Developments
Table 113. Qiagen Business Overview
Table 114. Qiagen Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Qiagen Primary Care POC Diagnostics Product
Table 116. Qiagen Response to COVID-19 and Related Developments
Table 117. Roche Business Overview
Table 118. Roche Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Roche Primary Care POC Diagnostics Product
Table 120. Roche Response to COVID-19 and Related Developments
Table 121. SDIX Business Overview
Table 122. SDIX Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. SDIX Primary Care POC Diagnostics Product
Table 124. SDIX Response to COVID-19 and Related Developments
Table 125. Sequenom Business Overview
Table 126. Sequenom Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Sequenom Primary Care POC Diagnostics Product
Table 128. Sequenom Response to COVID-19 and Related Developments
Table 129. Siemens Business Overview
Table 130. Siemens Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Siemens Primary Care POC Diagnostics Product
Table 132. Siemens Response to COVID-19 and Related Developments
Table 133. Sienco Business Overview
Table 134. Sienco Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Sienco Primary Care POC Diagnostics Product
Table 136. Sienco Response to COVID-19 and Related Developments
Table 137. Sysmex Business Overview
Table 138. Sysmex Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Sysmex Primary Care POC Diagnostics Product
Table 140. Sysmex Response to COVID-19 and Related Developments
Table 141. Takara Bio Business Overview
Table 142. Takara Bio Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Takara Bio Primary Care POC Diagnostics Product
Table 144. Takara Bio Response to COVID-19 and Related Developments
Table 145. ThermoFisher Business Overview
Table 146. ThermoFisher Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. ThermoFisher Primary Care POC Diagnostics Product
Table 148. ThermoFisher Response to COVID-19 and Related Developments
Table 149. Tosoh Business Overview
Table 150. Tosoh Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 151. Tosoh Primary Care POC Diagnostics Product
Table 152. Tosoh Response to COVID-19 and Related Developments
Table 153. Wako Business Overview
Table 154. Wako Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 155. Wako Primary Care POC Diagnostics Product
Table 156. Wako Response to COVID-19 and Related Developments
Table 157. Zycare/Alere Business Overview
Table 158. Zycare/Alere Primary Care POC Diagnostics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 159. Zycare/Alere Primary Care POC Diagnostics Product
Table 160. Zycare/Alere Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Primary Care POC Diagnostics Product Picture
Figure 2. Primary Care POC Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Primary Care POC Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Primary Care POC Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Primary Care POC Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Primary Care POC Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Primary Care POC Diagnostics Market Size Market Share, 2019-2021
Figure 1. Primary Care POC Diagnostics Product Picture
Figure 2. Primary Care POC Diagnostics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Primary Care POC Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Primary Care POC Diagnostics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Primary Care POC Diagnostics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Primary Care POC Diagnostics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Primary Care POC Diagnostics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Primary Care POC Diagnostics Market Size Market Share, 2019-2021
